share_log

大行评级|花旗:维持平安好医生“买入”评级 目标价下调至35港元

Bank Rating|Citibank: Maintaining Safe Good Doctor's “Buy” Rating Target Price Lowered to HK$35

Gelonghui Finance ·  Aug 28, 2023 11:19
GLONGHUI, August 28 | Citigroup published a research report stating that Ping An Good Doctor's income for the first half of the year fell 21.4% year-on-year to 2,222 billion yuan, 26% and 30% lower than market expectations and the bank's expectations, respectively; net loss of 245 million yuan, narrower than the decline of 462 million yuan in the same period last year, would beat expectations. Gross margin increased from 27.3% in the first half of last year to 32.2%, mainly due to a shift from a high-profit business to a high-profit business strategy. The bank lowered Ping An Good Doctor's revenue forecast from 2023 to 2025 by 25%, 23%, and 20% to reflect the decline in revenue brought about by exiting the lower gross margin business. The target price was lowered from HK$40 to HK$35, maintaining the “buy” rating.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment